Global Defibrillators Market Size By End User(Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets), By Product(Implantable Cardioverter Defibrillators (ICDS), External Defibrillators), By Geographic Scope And Forecast
제세동기 시장 규모와 예측
제세동기 시장 규모는 2020년에 108억 8,000만 달러로 평가되며, 2021-2028년 CAGR 5.60%로 성장하며, 2028년에는 167억 2,000만 달러에 달할 것으로 예측됩니다.
대상 질환의 위험이 가장 높은 고령 인구 증가, 심장질환 발생률 증가, 공공 접근성 제세동기 제공에 대한 관심 증가는 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 세계의 제세동기 시장 보고서는 시장에 대한 종합적인 평가를 제공합니다. 주요 부문, 동향, 시장 성장 촉진요인, 억제요인, 경쟁 환경, 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석합니다.
제세동기 시장의 정의
제세동기는 무정맥성 심실빈맥, 부정맥, 심실세동과 같은 심각한 상태에서 환자의 심장에 치료용 충격을 가하는 데 사용되는 전자 기기입니다. 전기 충격은 심장 근육을 탈분극시켜 정상적인 전기 자극을 회복시킵니다. 생명을 위협하는 부정맥으로 고통받는 사람들의 갑작스런 죽음을 예방할 수 있습니다. 제세동기의 최종사용자는 병원, 진료소, 심장센터, 예비 병원, 공공 접근 시장, 재택치료, 대체 의료 시장입니다. 제품에 따라 이식형 제세동기(ICD), 체외 제세동기, 수동형 체외 제세동기, 착용형 제세동기(WCD)로 나뉩니다.
세동세계의 제세동기 시장 개요
대상 질환의 위험이 가장 높은 노인 인구 증가와 공공 접근성 제세동기 제공에 대한 관심이 높아짐에 따라 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 또한 제세동기 관련 교육 및 인식 제고 프로그램, 심장질환 발생률 증가는 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 또한 CRT-Ds, S-ICD, MRI 지원 ICD의 개발이 진행되고 있습니다.
시장 성장을 저해하는 억제요인과 과제들도 존재합니다. 갑작스런 심장마비(SCA)에 대한 인식 부족, 제품 결함 등의 요인이 시장 성장 억제요인으로 작용할 가능성이 높습니다.
목차
제1장 세계의 제세동기 시장의 서론
제2장 개요
제3장 VERIFIED MARKET RESEARCH의 조사 방법
- 데이터 마이닝
- 밸리데이션
- 일차 자료
- 데이터 소스 리스트
제4장 세계의 제세동기 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
- 규제 프레임워크
제5장 세계의 제세동기 시장 : 최종사용자별
- 병원, 클리닉, 심장 센터
- 프레 병원
- 공공 액세스 시장
- 재택 의료
- 대체 의료 시장
제6장 세계의 제세동기 시장 : 제품별
- 이식형 제세동기(ICD)
- 이식형 제세동기(T-ICD)
- 피하 이식형 제세동기(S-ICD)
- 체외식 제세동기
- 수동식 체외식 제세동기
- 장착형 제세동기(WCD)
제7장 세계의 제세동기 시장 : 지역별
- 개요
- 북미 지역의 시장 추산·예측, 2012-2025년
- 유럽 지역의 시장 추산·예측, 2012-2025년
- 아시아태평양의 시장 추산·예측, 2012-2025년
- 라틴아메리카 지역의 시장 추산·예측, 2012-2025년
- 세계의 기타 지역의 시장 추산·예측, 2012-2025년
제8장 세계의 제세동기 시장 경쟁 구도
- 개요
- 기업 시장 점유율
- 벤더 구도
- 주요 개발 전략
제9장 기업 개요
- Medtronic PLC
- St. Jude Medical, Inc.
- Boston Scientific Corporation
- Philips Healthcare
- Zoll Medical Corporation
- Biotronik Se & Co.Kg
- Physio-Control International, Inc.
- Cardiac Science Corporation
- Sorin Group
- Nihon Kohden Corporation
제10장 부록
KSA
Defibrillators Market Size And Forecast
Defibrillators Market size was valued at USD 10.88 Billion in 2020 and is projected to reachUSD 16.72 Billion by 2028, growing at aCAGR of 5.60% from 2021 to 2028.
The growing geriatric population having the highest risk of target diseases, rising incidence of cardiac diseases, and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. The Global Defibrillators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Defibrillators Market Definition
A defibrillator is an electronic device used to deliver a therapeutic shock to a patient's heart in serious conditions like pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock depolarizes the heart muscles and restores its normal electric impulse. It can prevent sudden death among people suffering from life-threatening arrhythmia. End-Users of defibrillators are Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. Based on the product, they are classified into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS).
Global Defibrillators Market Overview
The growing geriatric population having the highest risk of target diseases and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. Also, training & awareness programs on defibrillators and the rising incidence of cardiac diseases expects a boost to the market in the coming years. Additionally, the development of CRT-Ds, S-ICDs, and MRI-compatible ICDs
There are certain restraints and challenges faced which can hinder the market growth. Factors such as lack of awareness about the sudden cardiac arrest (SCA) and product failures are likely to act as market restraints.
Global Defibrillators Market: Segmentation Analysis
The Global Defibrillators Market is Segmented into End User, Product, And Geography.
Defibrillators Market by End-User
Hospitals, Clinics, & Cardiac Centers
Pre-Hospitals
Home Care
Alternate Care Markets
Based on the end-user, the market is bifurcated into Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. The Hospitals, Clinics, & Cardiac Centers segment is predicted to hold the largest market share. The factors can be attributed to the availability of reimbursements facilities and upsurge in the number of cardiac implant procedures.
Defibrillators Market by Product
Implantable Cardioverter Defibrillators (ICDS)
Implantable Cardioverter Defibrillators (T-ICDS)
Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
Dual-Chamber ICDS
Single-Chamber ICDS
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
External Defibrillators
Automated External Defibrillators (AEDS)
Semi-Automated External Defibrillators
Fully Automated External Defibrillators
Manual External Defibrillators
Wearable Cardioverter Defibrillators (WCDS)
Based on the product, the market is bifurcated into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS). The Implantable Cardioverter Defibrillators (ICDS) segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) & S-ICD systems across the globe and the development of technologically advanced devices with extended longevity.
Defibrillators Market by Geography
Based on regional analysis, the Global Defibrillators Market is classified into
North America
Europe
Asia Pacific
Rest of the world
The largest share in the market will be dominated by North America owing to the technological advancements, increasing the geriatric population, and the prevalence of cardiac diseases in this region.
Key Players
The Major Players in the market are as follows:
- Medtronic PLC
- St. Jude Medical, Inc.
- Boston Scientific Corporation
- Philips Healthcare (A Division of Koninklijke Philips N.V.)
- Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
- Biotronik Se & Co.Kg
- Physio-Control International, Inc.
- Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
- orin Group (Now Livanova PLC)
- Nihon Kohden Corporation
These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Key Developments
Product Launches and Product Expansions
- On April 2020, Philips, a health technology company, announced that the Emergency Care and Resuscitation (ECR) business is recommencing the US manufacturing and shipping of external defibrillators. The company notified that the US Food and Drug Administration (FDA) had lifted the restrictions imposed on the manufacturing and distribution of defibrillators in the US.
- On March 2021, The Rankin government announced that all public schools in Nova Scotia would be provided automated external defibrillators. The government invested USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.
- On July 2021, ZOLL Medical Corporation announced that the company had received clearance from FDA 510(k) to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provided clinical decision support for managing patients with TBI and was available in international markets, but it is now available in the U.S. market with the FDA clearance.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 4.5 Regulatory Framework
5 Global Defibrillators Market, By End User
- 5.1 Hospitals, Clinics, & Cardiac Centers
- 5.2 Pre-Hospitals
- 5.3 Public Access Markets
- 5.4 Home Care
- 5.5 Alternate Care Markets
6 Global Defibrillators Market, By Product
- 6.1 Implantable Cardioverter Defibrillators (ICDS)
- 6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
- 6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
- 6.1.1.2 Dual-Chamber ICDS
- 6.1.1.3 Single-Chamber ICDS
- 6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
- 6.2 External Defibrillators
- 6.2.1 Automated External Defibrillators (AEDS)
- 6.2.1.1 Semi-Automated External Defibrillators
- 6.2.1.2 Fully Automated External Defibrillators
- 6.3 Manual External Defibrillators
- 6.4 Wearable Cardioverter Defibrillators (WCDS)
7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY
- 7.1 Overview
- 7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
- 7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
- 7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
- 7.5.1 Brazil
- 7.5.2 Argentina
- 7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 a€" 2025
8 GLOBAL DEFIBRILLATORS MARKET COMPETITIVE LANDSCAPE
- 8.1 Overview
- 8.2 Company Market Share
- 8.3 Vendor Landscape
- 8.4 Key Development Strategies
9 COMPANY PROFILES
- 9.1 Medtronic PLC
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 St. Jude Medical, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 Boston Scientific Corporation
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 Philips Healthcare
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 Zoll Medical Corporation
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Biotronik Se & Co.Kg
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Physio-Control International, Inc.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 9.8 Cardiac Science Corporation
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
- 9.9 Sorin Group
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
- 9.10 Nihon Kohden Corporation
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
10 Appendix
